SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabets quarterly results missed expectations, with slowing Search and ad growth alongside heavy AI infrastructure spending and negative free cash flow weighing on shares despite strong Cloud growth. Traders are debating whether the selloff reflects real risks to Search monetization and spending returns or an overreaction to a strong-growth business, with many bullish voices describing it as a buying opportunity.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances announcement of positive Phase 2 lifileucel results in previously treated metastatic lung cancer, alongside an update on its precision-medicine strategy, is driving attention as traders weigh the therapys potential beyond melanoma. Many are bullish, while others caution that the detailed data still matter and debate whether the sharp move could be followed by profit-taking; short-squeeze talk remains speculative.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Alphabets earnings miss and higher AI-spending outlook have fueled concern about tech valuations and their effect on the broader market, while traders also weigh the Feds rate hold and upcoming inflation and growth data. Bulls point to SPYs resilience and dip-buying, while bears warn of further volatility and downside.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL AML trial reached its prespecified 80th event, triggering final analysis and setting up a topline readout expected this quarter; the update did not disclose whether the treatment improved survival. Shares fell sharply, prompting debate over a sell-the-news reaction versus concern about the still-uncertain trial outcome, while bullish traders are focused on the pending data.

Alphabet Inc - Ordinary Shares - Class C

Alphabets earnings miss and heavy AI infrastructure spending, which pressured cash flow and came alongside slower Search and ad growth, are driving the selloff discussion. Traders are split between concerns about spending returns and AI-driven search competition, and dip-buyers pointing to strong Google Cloud growth and the companys longer-term prospects.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows mixed Q3 resultsan earnings miss and a softer forecast for near-term contracted revenue growthsparked a sharp selloff despite revenue growth and a higher AI-contract target. Traders are divided between calling the drop an overreaction to strong underlying demand and warning that slowing growth, high expectations, and AI disruption risks weigh on ServiceNow and the broader software sector.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts quarterly results beat expectations, with accelerating Azure growth and lower-than-expected capital spending driving a positive reaction and comparisons favoring Microsoft over Alphabet. Traders remain divided over whether strong cloud demand and AI monetization outweigh concerns about free-cash-flow pressure and the stocks fading post-earnings gains.

Fervo Energy Co. operates as a energy company. It builds and operates power facilities in extracting geothermal energy. The company was founded by Jack Norbeck and Timothy Latimer in 2017 and is headquartered in Berkeley, CA.

Fervo Energy Co. - Ordinary Shares - Class A

Fervo Energy Co

Morpheus Researchs bearish report questioning Fervos geothermal performance, water recovery and commercial viability is fueling concern alongside the stocks steep decline. Bulls call the report a short-seller hit piece and cite Cape Stations first power and Google-backed demand, while bears remain focused on execution risks and potential selling after the lockup expires.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs steep selloff and repeated 52-week lows dominate discussion, with traders pointing to concerns about slower growth, delayed ad rollout and content engagement. Sentiment is split between frustrated bears expecting further declines and investors who see the weakness and lower valuation as a buying opportunity.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Alphabets earnings miss and heavy AI-spending concerns sparked debate over whether weakness in the company could weigh on the Nasdaq and broader AI trade. QQQ traders were split between buying the dip and expecting a rebound, and warning that the selloff signaled deeper risks to tech valuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ELAN: the Advantix deal is not just $9.275M. Elanco agreed to drop its alleged exclusivity discount for 5 years, and retailers must consider carrying a generic rival for a year. Claim form Jan 8, due Feb 25. Open Class Actions.

StockTwits Web

Elanco Animal Health Inc

: the Advantix deal is not just $9.275M. Elanco agreed to drop its alleged exclusivity discount for 5 years, and retailers must consider carrying a generic rival for a year. Claim form Jan 8, due Feb 25. Open Class Actions.